HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC Permethrin For Lice Still Endorsed Despite Latest Resistance Research

This article was originally published in The Rose Sheet

Executive Summary

Continued use of permethrin as the front-line treatment for newly diagnosed infestations of head lice is advised by Harvard researchers despite new data showing some lice in the U.S. are resistant to the ingredient. Several OTC lice products, such as Warner-Lambert's Nix, contain permethrin as an active ingredient.

You may also be interested in...



Pediculicide Resistance Not Well Understood - Lancet Editorial

The mechanism by which head lice become resistant to pediculicides needs further study, Howard Maibach, MD, University of California at San Francisco, et al., suggest in the Aug. 12 issue of The Lancet.

Pediculicide Resistance Not Well Understood - Lancet Editorial

The mechanism by which head lice become resistant to pediculicides needs further study, Howard Maibach, MD, University of California at San Francisco, et al., suggest in the Aug. 12 issue of The Lancet.

CCA Industries Plus + White Toothpaste Case Referred To FTC By NAD

A false advertising case against CCA Industries Plus + White Shades Whiter and Plus + White Plus Peroxide stain remover toothpaste is being referred to the Federal Trade Commission for review.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel